(Q50558062)

15 March 2018

title

Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin. (English)

1 reference

15 March 2018

author name string

Donald R Branch

1

1 reference

15 March 2018

Terry L Scofield

2

1 reference

15 March 2018

John J Moulds

3

1 reference

15 March 2018

Jane L Swanson

4

1 reference

15 March 2018

publication date

7 October 2010

1 reference

15 March 2018

published in

Transfusion

1 reference

15 March 2018

volume

51

1 reference

15 March 2018

issue

4

1 reference

15 March 2018

page(s)

816-819

1 reference

15 March 2018

Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

Experimental studies on the prevention of Rh haemolytic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

Successful Prevention of Experimental Rh Sensitization in Man with an Anti‐Rh Gamma2‐Globulin Antibody Preparation: A Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcgamma receptor-mediated phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02905.X

10.1111/J.1537-2995.2010.02905.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018